Jane Street’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-377,900
| Closed | -$14.9M | – | 9750 |
|
|
2023
Q2 | $14.9M | Buy |
377,900
+210,500
| +126% | +$7.43M | 0.01% | 1497 |
|
|
2023
Q1 | $4.07M | Sell |
167,400
-5,000
| -3% | -$109K | ﹤0.01% | 2728 |
|
|
2022
Q4 | $3.69M | Sell |
172,400
-357,100
| -67% | -$7.62M | ﹤0.01% | 2917 |
|
|
2022
Q3 | $9.5M | Buy |
529,500
+338,400
| +177% | +$4.44M | ﹤0.01% | 1751 |
|
|
2022
Q2 | $1.84M | Sell |
191,100
-65,500
| -26% | -$822K | ﹤0.01% | 4330 |
|
|
2022
Q1 | $4.32M | Buy |
256,600
+218,100
| +566% | +$3.22M | ﹤0.01% | 3282 |
|
|
2021
Q4 | $644K | Sell |
38,500
-159,400
| -81% | -$2.61M | ﹤0.01% | 6793 |
|
|
2021
Q3 | $3.21M | Buy |
+197,900
| New | +$2.15M | ﹤0.01% | 3530 |
|
|
2017
Q1 | – | Sell |
-36,800
| Closed | -$178K | – | 4826 |
|
|
2016
Q4 | $178K | Buy |
+36,800
| New | +$1.09M | ﹤0.01% | 3770 |
|
|
2016
Q1 | – | Sell |
-3,600
| Closed | -$283K | – | 4779 |
|
|
2015
Q4 | $283K | Buy |
+3,600
| New | +$208K | ﹤0.01% | 3174 |
|
Jane Street's ISEE Position: Q3 2023 in Review
Jane Street sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 454,619 shares — an estimated $17.9M sold.
Jane Street first reported a position in ISEE in Q2 2014 and held it in 20 quarters. The position peaked at $17.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Jane Street reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Jane Street sold 454,619 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $17.9M.
- Jane Street first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 20 quarters.
- Jane Street's IVERIC bio, Inc. Common Stock position peaked at $17.9M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.